GGrantIndex
← Leaderboards

William A Boisvert

Scripps Research Institute

$7,973,329
Attributed
$8,920,535
Total exposure
8
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $799K · FY200517
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$8,920,535 · 8

By mechanism

R01$7,095,081 · 5
P30$1,351,773 · 1
U54$346,500 · 1
R29$127,181 · 1

Top collaborators

Most similar at Scripps Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Atherosclerosis

Research focus

AtherosclerosisMacrophagePhenotypeResearch PersonnelBone Marrow TransplantationMediatingMouse ModelArterial Fatty StreakAffectGenesCell AdhesionIn VivoIn VitroLeukocytesLaboratory MousePathologic ProcessGene ExpressionCholesterolCellsMigrationCytokineDesignAnimalsBase

Grant awards (27)

Monocytes and Macrophages in HIV Cardiovascular Risk$346,500
U54 · FY2017 · MD
Mouse Physiology Core$268,161
P30 · FY2016 · GM · contact PI
The Role of ABCC6 In Chronic & Acute Cardiovascular Mineralization$357,062
R01 · FY2015 · HL
Mouse Physiology Core$275,270
P30 · FY2015 · GM · contact PI
The Role of ABCC6 In Chronic & Acute Cardiovascular Mineralization$355,250
R01 · FY2014 · HL
Mouse Physiology Core$282,171
P30 · FY2014 · GM · contact PI
The Role of ABCC6 In Chronic & Acute Cardiovascular Mineralization$345,100
R01 · FY2013 · HL
Mouse Physiology Core$281,200
P30 · FY2013 · GM · contact PI
The role of ABCC6 in chronic and acute cardiovascular mineralization$375,000
R01 · FY2012 · HL
Mouse Physiology Core$244,971
P30 · FY2012 · GM · contact PI
Rho kinase in immune-mediated atherosclerosis$375,000
R01 · FY2010 · HL · contact PI
Rho kinase in immune-mediated atherosclerosis$375,000
R01 · FY2009 · HL · contact PI
Rho kinase in immune-mediated atherosclerosis$410,500
R01 · FY2008 · HL · contact PI
Anti-inflammatory Cytokines in Atherosclerosis$355,567
R01 · FY2008 · HL · contact PI
Anti-inflammatory Cytokines in Atherosclerosis$32,950
R01 · FY2008 · HL · contact PI
Rho kinase in immune-mediated atherosclerosis$410,500
R01 · FY2007 · HL · contact PI
Anti-inflammatory Cytokines in Atherosclerosis$388,517
R01 · FY2007 · HL · contact PI
Anti-inflammatory Cytokines in Atherosclerosis$400,121
R01 · FY2006 · HL · contact PI
Anti-inflammatory Cytokines in Atherosclerosis$409,395
R01 · FY2005 · HL
Macrophage migration in atherosclerosis$346,000
R01 · FY2004 · HL
Macrophage migration in atherosclerosis$346,000
R01 · FY2003 · HL
Macrophage migration in atherosclerosis$370,400
R01 · FY2002 · HL
THE CHEMOKINE RECEPTOR CXCR-2 IN ATHEROSCLEROSIS$368,551
R01 · FY2002 · HL
Macrophage migration in atherosclerosis$378,054
R01 · FY2001 · HL
THE CHEMOKINE RECEPTOR CXCR-2 IN ATHEROSCLEROSIS$357,569
R01 · FY2001 · HL
THE CHEMOKINE RECEPTOR CXCR-2 IN ATHEROSCLEROSIS$338,545
R01 · FY2000 · HL
LOCALLY PRODUCED APOLIPOPROTEIN E IN ATHEROSCLEROSIS$127,181
R29 · FY2000 · HL